Your browser doesn't support javascript.
loading
Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.
Wang, Xin; Li, You; O'Brien, Katherine L; Madhi, Shabir A; Widdowson, Marc-Alain; Byass, Peter; Omer, Saad B; Abbas, Qalab; Ali, Asad; Amu, Alberta; Azziz-Baumgartner, Eduardo; Bassat, Quique; Abdullah Brooks, W; Chaves, Sandra S; Chung, Alexandria; Cohen, Cheryl; Echavarria, Marcela; Fasce, Rodrigo A; Gentile, Angela; Gordon, Aubree; Groome, Michelle; Heikkinen, Terho; Hirve, Siddhivinayak; Jara, Jorge H; Katz, Mark A; Khuri-Bulos, Najwa; Krishnan, Anand; de Leon, Oscar; Lucero, Marilla G; McCracken, John P; Mira-Iglesias, Ainara; Moïsi, Jennifer C; Munywoki, Patrick K; Ourohiré, Millogo; Polack, Fernando P; Rahi, Manveer; Rasmussen, Zeba A; Rath, Barbara A; Saha, Samir K; Simões, Eric Af; Sotomayor, Viviana; Thamthitiwat, Somsak; Treurnicht, Florette K; Wamukoya, Marylene; Yoshida, Lay-Myint; Zar, Heather J; Campbell, Harry; Nair, Harish.
Affiliation
  • Wang X; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Li Y; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • O'Brien KL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Madhi SA; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Widdowson MA; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya; Institute of Tropical Medicine, Antwerp, Belgium.
  • Byass P; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
  • Omer SB; Yale Institute for Global Health; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Abbas Q; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Ali A; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Amu A; Dodowa Health Research Centre, Dodowa, Ghana.
  • Azziz-Baumgartner E; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Bassat Q; Barcelona Global Health Institute, Hospital Clínic-University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant
  • Abdullah Brooks W; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Chaves SS; Influenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Chung A; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Cohen C; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Echavarria M; Clinical Virology Unit, Centro de Educación Médica e Investigaciones Clínicas, Argentina.
  • Fasce RA; Public Health Institute of Chile, Región Metropolitana, Chile.
  • Gentile A; Ricardo Gutierrez Children Hospital, Buenos Aires, Argentina.
  • Gordon A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Groome M; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Finland.
  • Hirve S; Vadu Rural Health program, KEM Hospital Research Centre, Pune, Maharashtra, India.
  • Jara JH; Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
  • Katz MA; Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel; Ben Gurion University of the Negev, School of Public Health and Medical School for International Health, Beer-Sheva, Israel; University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Khuri-Bulos N; Department of Pediatrics, University of Jordan School of Medicine, Amman, Jordan.
  • Krishnan A; Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • de Leon O; Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
  • Lucero MG; ARI Study Group, Research Institute for Tropical Medicine, Muntinlupa, Philippines.
  • McCracken JP; Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
  • Mira-Iglesias A; Área de Investigación en Vacunas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Salud Pública), Valencia, Spain.
  • Moïsi JC; Agence de Médecine Préventive, Paris, France.
  • Munywoki PK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Ourohiré M; Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
  • Polack FP; Fundacion INFANT, Buenos Aires, Argentina.
  • Rahi M; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Rasmussen ZA; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
  • Rath BA; Vienna Vaccine Safety Initiative, Berlin, Germany.
  • Saha SK; Department of Microbiology, Child Health Research Foundation, Dhaka, Bangladesh.
  • Simões EA; Department of Pediatrics, Section of Infectious Diseases, University of Colorado, School of Medicine, Aurora, CO, USA; Department of Epidemiology and Center for Global Health, Colorado School of Public Health, Aurora CO, USA.
  • Sotomayor V; Epidemiology Department, Ministry of Health, Santiago, Chile.
  • Thamthitiwat S; Division of Global Health Protection, Thailand Ministry of Public Health; US CDC Collaboration, Nonthaburi, Thailand.
  • Treurnicht FK; Department of Medical Virology, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Wamukoya M; African Population & Health Research Center, Nairobi, Kenya.
  • Yoshida LM; Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Zar HJ; Department of Paediatrics & Child Health and Medical Research Council unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.
  • Campbell H; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Nair H; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK. Electronic address: harish.nair@ed.ac.uk.
Lancet Glob Health ; 8(4): e497-e510, 2020 04.
Article in En | MEDLINE | ID: mdl-32087815
BACKGROUND: Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. METHODS: We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. FINDINGS: In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. INTERPRETATION: A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. FUNDING: WHO; Bill & Melinda Gates Foundation.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Global Health / Influenza, Human Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Child, preschool / Humans / Infant / Newborn Language: En Journal: Lancet Glob Health Year: 2020 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Global Health / Influenza, Human Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Child, preschool / Humans / Infant / Newborn Language: En Journal: Lancet Glob Health Year: 2020 Document type: Article Country of publication: United kingdom